Navigation Links
'Disprin Plus' is now 'Disprin Paracetamol'

Reckitt Benckiser has deferred the launch of 'Disprin CV' (cardiovascular) following the confusion over the name of its new painkiller 'Disprin Plus', the company's Regional Director , Mr. Pranab Barua said. The company also announced a change in the brand-name 'Disprin Plus' to 'Disprin Paracetamol'. Subsequent to the launch of Disprin Plus, there were reports citing instances of concern from doctors and consumers regarding the use of the suffix 'Plus' along with the brand-name, Mr. Barua said.

"This matter was also taken up by the drug aythorities and the company was advised to address this concern.// Taking cognisance of the concern of consumers and the drug authorities, the company decided to change the suffix from 'Plus' to 'Paracetamol', thereby making clear the brand's ingredient ," he said.

Mr. Barua said that the company, which had an inventory of 15 - 20 million tablets worth about Rs 1 crore, will suffer loss of sale for a month during the transition period to the tune of Rs 1.5 - 2 crore. Disprin 'Paracetamol' will be in the market by mid-December , he said. The company has also decided not to give any brand push to Disprin Cold and Flu for similar reasons, Mr. Baura said.

Paracetamol-based Disprin 'Plus' was launched by Reckitt Benckiser (India) in August this year to replace Disprin (350 mg aspirin) in the pain relief segment. Mr. Barua said Disprin CV (100 mg aspirin) will not be launched till the new brand 'Disprin Paracetamol' is completely established.


'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves drug for rare liver disease
3. FDA approves first pocket-sized EKG machine
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
6. Madras High Court Disapproves of Comparative Advertisements
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. New spray gel heals surgical wounds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
(Date:2/5/2016)... ... 05, 2016 , ... VeloReality President and co-founder ... LYNX VR Indoor Trainer with multi-rider capability to an enthusiastic audience at the ... reduce the weight of the unit, they also enhance the rider's experience with ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official operators ... to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the ... Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one of the nation’s ... weekend’s Big Game. Take the stress out of your party preparation – follow these ... at every stage of the game. , “The key to hosting a successful game-day ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide Radiology ... significant growth as next generation systems provide a ... radiology for cancer surgery. New systems pinpoint the ... that has been such a problem previously, limiting ... Radiosurgery robots take cancer surgery far beyond what ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... Summary Global Markets Direct,s, ,Wegener Polyangiitis - ... the Wegener Polyangiitis,s therapeutic pipeline. This report ... Wegener Polyangiitis, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:2/4/2016)... 2016 Global Immunology Market to 2022 ... long-term market growth Summary Immune-mediated inflammatory ... disorders that affect 5–7% of western populations. Although ... symptoms and key patient demographics, they are pathophysiologically ... and an inappropriate immune response. Generally, disease-modifying anti-rheumatic ...
Breaking Medicine Technology: